1

Alirocumab (1245916-14-6): A Deep Dive

wcd118084573
Alirocumab, identified by 1245916-14-6, signifies a recently developed monoclonal immunoglobulin specifically to target proprotein convertase subtilisin-kexin type 9 – a key regulator of "bad" cholesterol https://www.targetmol.com/compound/alirocumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story